12 13 Butterflies Healthcare Limited 05475756 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is that of import, distribution and retail of a range of eye health products. Digita Accounts Production Advanced 6.30.9574.0 true 05475756 2025-04-01 2026-03-31 05475756 2026-03-31 05475756 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2026-03-31 05475756 core:CurrentFinancialInstruments 2026-03-31 05475756 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 05475756 core:Goodwill 2026-03-31 05475756 core:PatentsTrademarksLicencesConcessionsSimilar 2026-03-31 05475756 core:FurnitureFittings 2026-03-31 05475756 core:LandBuildings core:ShortLeaseholdAssets 2026-03-31 05475756 core:OfficeEquipment 2026-03-31 05475756 bus:SmallEntities 2025-04-01 2026-03-31 05475756 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 05475756 bus:FilletedAccounts 2025-04-01 2026-03-31 05475756 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 05475756 bus:RegisteredOffice 2025-04-01 2026-03-31 05475756 bus:CompanySecretaryDirector1 2025-04-01 2026-03-31 05475756 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2025-04-01 2026-03-31 05475756 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 05475756 core:Goodwill 2025-04-01 2026-03-31 05475756 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-03-31 05475756 core:PatentsTrademarksLicencesConcessionsSimilar 2025-04-01 2026-03-31 05475756 core:ComputerEquipment 2025-04-01 2026-03-31 05475756 core:FurnitureFittings 2025-04-01 2026-03-31 05475756 core:LandBuildings 2025-04-01 2026-03-31 05475756 core:LandBuildings core:ShortLeaseholdAssets 2025-04-01 2026-03-31 05475756 core:OfficeEquipment 2025-04-01 2026-03-31 05475756 countries:EnglandWales 2025-04-01 2026-03-31 05475756 2025-03-31 05475756 core:Goodwill 2025-03-31 05475756 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 05475756 core:FurnitureFittings 2025-03-31 05475756 core:LandBuildings core:ShortLeaseholdAssets 2025-03-31 05475756 core:OfficeEquipment 2025-03-31 05475756 2024-04-01 2025-03-31 05475756 2025-03-31 05475756 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2025-03-31 05475756 core:CurrentFinancialInstruments 2025-03-31 05475756 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 05475756 core:Goodwill 2025-03-31 05475756 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 05475756 core:FurnitureFittings 2025-03-31 05475756 core:LandBuildings core:ShortLeaseholdAssets 2025-03-31 05475756 core:OfficeEquipment 2025-03-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 05475756

Butterflies Healthcare Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2026

Butterflies Healthcare Limited

(Registration number: 05475756)
Balance Sheet as at 31 March 2026

| Note | 2026 £ | 2025 £
Fixed assets |  |  |
Intangible assets | 4 | 110,589 | 123,994
Tangible assets | 5 | 19,510 | 18,795
|  | 130,099 | 142,789
Current assets |  |  |
Stocks | 6 | 476,113 | 436,093
Debtors | 7 | 47,754 | 56,290
Cash at bank and in hand |  | 301,956 | 199,142
|  | 825,823 | 691,525
Creditors: Amounts falling due within one year | 8 | (322,708) | (245,909)
Net current assets |  | 503,115 | 445,616
Total assets less current liabilities |  | 633,214 | 588,405
Provisions for liabilities |  | - | (1,947)
Net assets |  | 633,214 | 586,458
Capital and reserves |  |  |
Called up share capital | 9 | 2 | 2
Retained earnings |  | 633,212 | 586,456
Shareholders' funds |  | 633,214 | 586,458

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Butterflies Healthcare Limited

(Registration number: 05475756)
Balance Sheet as at 31 March 2026 (continued)

Approved and authorised by the Board on 4 August 2026 and signed on its behalf by:

Mr J A Sutton Company secretary and director |  |

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 1 Wildmere Close
Wildmere Industrial Estate
Banbury
OX16 3TL

These financial statements were authorised for issue by the Board on 4 August 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

2 | Accounting policies (continued)

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Contract revenue recognition

Revenue from contracts for the provision of professional services is recognised when the stage of completion of the transaction can be reliably measured.

Government grants

Government grants are recognised at the fair value of the claimable amount when there is reasonable assurance that the company will comply with conditions attaching to the grant.
Government grants are accounted for on the accruals basis.

Foreign currency transactions and balances

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in the profit and loss account.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

2 | Accounting policies (continued)

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of the deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing differences arise from goodwill or from initial recognition of other assets and liabilities in a transaction that affects neither the tax profit not the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Fixtures and fittings | 25% reducing balance
Computers | 20% reducing balance or 25% straight line
Leasehold property improvements | 16.67% straight line

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

2 | Accounting policies (continued)

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Intangible assets

Intangible assets are trademarks held by the company and are initially recognised at cost, and subsequently recognised at cost less any accumulated amortisation and impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Trademarks | 5 years
Goodwill | 10 years

Investments

Investments in listed shares are valued at fair value and the gain or loss on this investment is recognised in the profit and loss account.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

2 | Accounting policies (continued)

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

2 | Accounting policies (continued)

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
The company has elected to apply the provision of Section 11 "Basic Financial Instruments" and Section 12 "Other Financial Instruments" of FRS102 to all of its financial instruments.
Recognition and measurement
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2025 - 13).

4 | Intangible assets

| Goodwill £ | Trademarks, patents and licenses £ | Total £
Cost or valuation
At 1 April 2025 | 134,048 | 4,777 | 138,825
At 31 March 2026 | 134,048 | 4,777 | 138,825
Amortisation
At 1 April 2025 | 10,054 | 4,777 | 14,831
Amortisation charge | 13,405 | - | 13,405
At 31 March 2026 | 23,459 | 4,777 | 28,236
Carrying amount
At 31 March 2026 | 110,589 | - | 110,589
At 31 March 2025 | 123,994 | - | 123,994

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

5 | Tangible assets

| Short leasehold land and buildings £ | Fixtures and fittings £ | Office equipment £ | Total £
Cost or valuation
At 1 April 2025 | 10,010 | 7,112 | 24,269 | 41,391
Additions | - | - | 9,352 | 9,352
Disposals | - | - | (15,211) | (15,211)
At 31 March 2026 | 10,010 | 7,112 | 18,410 | 35,532
Depreciation
At 1 April 2025 | 1,530 | 4,187 | 16,879 | 22,596
Charge for the year | 1,668 | 731 | 3,630 | 6,029
Eliminated on disposal | - | - | (12,603) | (12,603)
At 31 March 2026 | 3,198 | 4,918 | 7,906 | 16,022
Carrying amount
At 31 March 2026 | 6,812 | 2,194 | 10,504 | 19,510
At 31 March 2025 | 8,480 | 2,925 | 7,390 | 18,795

Included within the net book value of land and buildings above is £6,812 (2025 - £8,480) in respect of short leasehold land and buildings.

6 | Stocks

| 2026 £ | 2025 £
Finished goods and goods for resale | 476,113 | 436,093

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

7 | Debtors

Current | 2026 £ | 2025 £
Trade debtors | 32,666 | 51,289
Prepayments | 10,088 | -
Other debtors | 5,000 | 5,001
| 47,754 | 56,290

8 | Creditors

Creditors: amounts falling due within one year

| 2026 £ | 2025 £
Due within one year |  |
Loans and borrowings | - | 635
Trade creditors | 158,433 | 156,363
Taxation and social security | 123,133 | 59,377
Accruals and deferred income | 2,815 | 2,815
Other creditors | 38,327 | 26,719
| 322,708 | 245,909

9 | Share capital

Allotted, called up and fully paid shares

| 2026 | 2025
| No. | £ | No. | £
Ordinary shares of £1 each | 2 | 2 | 2 | 2

Butterflies Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026 (continued)

10 | Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £37,500 (2025 - £67,500).